Skubal's Fast-Track Return Could Reshape Tigers Rotation — and Betting Totals

Tarik Skubal underwent surgery last week to remove loose bodies from his elbow, a procedure that typically sidelines pitchers for two to three months. But his agent, Scott Boras, appeared on ESPN's Baseball Tonight podcast over the weekend with a bullish revision: the minimally invasive NanoScope technique used by Dr. Neal ElAttrache could have the two-time Cy Young winner throwing meaningful innings by late June. That timeline hinges on one crucial fact—the less-invasive the surgery, the faster the rehabilitation ladder. Boras framed it as nearly equivalent to receiving an injection, which would compress both the initial recovery window and the arm-strength ramp-up phase.

Yes, Boras has a financial incentive to accelerate the Skubal narrative. The ace is a free-agent-to-be in a historically thin 2027 class, and a shortened timeline now protects his market value later. The Tigers organization, to their credit, have declined to commit to any public return date, which is the sensible move. Still, Boras's claim isn't pure theater. The NanoScope technology is legitimately less traumatic than traditional elbow surgery, and Skubal's track record—3-2 with a 2.70 ERA, 0.95 WHIP and 45 strikeouts in 43⅓ innings across seven starts this season—suggests a pitcher with mechanics and arm health intact before the procedure.

The Tigers' rotation context sharpens the stakes. Detroit sits 19-22 and tied for third in the AL Central, only 1½ games behind the Guardians despite the entire division having a losing record. Skubal is their ace, their strikeout anchor, the pitcher who can pile up swings and misses at a 10+ K/9 rate. His presence (or absence) reshapes the team's total ceiling dramatically. A June return would give Detroit their ace back with two months of regular season runway—enough to solidify a playoff push if the early-season collapse doesn't prove fatal.

For bettors, the Skubal timeline materializes in two ways. First: Tigers team totals are presently calibrated to a rotation without their ace or with him unavailable. Any credible June return probability should nudge Detroit totals upward across the July-September stretch—fewer rest days, fewer spot starts, more consistent run support from a defined rotation. Second, and more immediate, is the strikeout market. When Skubal does return, his K props (likely to be posted in the 9.5-11.5 range depending on innings pitched) will carry elevated ceiling risk given his elite whiff rate and the likely rust factor cutting both ways early. Teams will also adjust their team totals against him in the short term, anticipating elevated strikeout environments.

The honest read is that Boras's projection carries plausibility, but the Tigers themselves haven't committed to it. That gap between agent optimism and organizational caution is where the value lives for bettors. Assume a mid-to-late June return, not early June. That still meaningfully widens Detroit's pitching depth for the stretch run, but it tempers expectations for a sudden rotation transformation. The AL Central will likely be decided before Skubal's arm is fully back in rhythm.